ClinicalTrials.Veeva

Menu

SEARCH SAPPHIRE Phase A: A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa (SAPPHIRE PhA)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Hypertension
HIV
Maternal Child Health
Cost Effectiveness
Alcohol Drinking

Treatments

Other: PrEP/PEP at Outpatient Clinics
Other: Health Living Intervention for Heavy Alcohol Users
Other: Hypertension Linkage
Other: PrEP/PEP at Community Households
Other: Standard of Care
Other: Hypertension Community
Other: PrEP/PEP at Antenatal Clinics
Other: Mobility Dynamic Treatment Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04810650
U01AI150510 (U.S. NIH Grant/Contract)
SEARCH SAPPHIRE Phase A

Details and patient eligibility

About

The randomized trials in this record will assess effectiveness, fidelity and cost of prevention and treatment interventions for HIV and hypertension with the objective of informing a population-based study of multi-sectored, multi-disease interventions for HIV.

Full description

The study will conduct randomized trials to assess effectiveness, fidelity and cost of prevention and treatment interventions. The study will conduct two randomization trials to evaluate dynamic treatment interventions tailored to the needs of heavy alcohol users and mobile populations. The study will conduct three randomized trials to evaluate dynamic choice prevention interventions delivered in the context of antenatal clinics, the outpatient department, and in the community delivered by village health teams. The trial will conduct a randomized trial to evaluate a linkage intervention for patients with hypertension and a randomized trial to evaluate a clinic vs. community based intervention for hypertension.

Enrollment

2,233 patients

Sex

All

Ages

15+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

INDIVIDUAL LEVEL INCLUSION CRITERIA FOR COMPONENT INTERVENTIONS

PrEP/PEP at Outpatient Clinics

  1. Age ≥15 years
  2. HIV-negative
  3. Current or anticipated risk for HIV-infection

PrEP/PEP at Antenatal Clinics

  1. Age ≥15 years
  2. HIV-negative
  3. Current or anticipated risk for HIV-infection

PrEP/PEP at Community Households

  1. Age > 15 years
  2. HIV-negative
  3. Current or anticipated risk for HIV-infection

Mobility Dynamic Treatment Intervention

  1. Age ≥15 years
  2. HIV-positive
  3. HIV RNA non-suppression (>400 c/mL in the prior 12 months) or missed 2 visits in past 12 months or missed 2 visits in past 12 months or no VL measured in past 12 months
  4. Travel outside the community ≥2 times in past 12 months
  5. Enrolled or new to care in a study clinic

Healthy Living Intervention for Heavy Alcohol Users

  1. Age ≥18 years
  2. HIV-positive
  3. HIV RNA non-suppression (>400 c/mL in the prior 12 months) or missed clinic visits (>2 weeks or <=90 days from last scheduled clinic visit) within past 6 months, or out of care without return to care (>90 days from last scheduled clinic visit) within past 6 months
  4. Heavy alcohol use per AUDIT-C tool (scores of ≥4 for men, and ≥3 for women)
  5. Enrolled or new to care in a study clinic

Hypertension Linkage Intervention

  1. Age ≥25 years
  2. Blood pressure ≥140/90 mmHg on three repeated measurements during community-based hypertension screening
  3. Resident (by self-report) within catchment area of referral health center

Community Hypertension Intervention

  1. Age >=40
  2. Blood pressure ≥160/100 on average of 2nd and 3rd measurements at initial screening
  3. Sustained blood pressure elevation to ≥140/90 at initial clinic enrollment visit

INDIVIDUAL LEVEL EXCLUSION CRITERIA FOR COMPONENT INTERVENTIONS

PrEP/PEP at Outpatient Clinics

  1. <15 years of age
  2. Unable to provide consent or parental co-consent as per country guidelines
  3. Participation in another Phase A RCT intervention component

PrEP/PEP at Antenatal Clinics

  1. <15 years of age
  2. unable to provide consent or parental co-consent as per country guidelines
  3. Participation in another Phase A RCT intervention component

PrEP/PEP at Community Households

  1. <15 years of age
  2. unable to provide consent or parental co-consent as per country guidelines
  3. Participation in another Phase A RCT intervention component

Mobility Dynamic Treatment intervention

  1. <15 years of age
  2. Participation in another Phase A RCT intervention component

Healthy Living Intervention for Heavy Alcohol Users

  1. <18 years of age
  2. Participation in another Phase A RCT intervention component
  3. No access to mobile phone

Hypertension Linkage Intervention

  1. <25 years of age
  2. Plan to out-migrate from the catchment area of referral health center within 30 days of screening visit
  3. Already engaged in hypertensive care (by self-report)
  4. Blood pressure measure of ≥180/110 mmHg during screening symptoms of hypertensive emergency

Community Hypertension Intervention

  1. Pregnancy
  2. Co-morbidities that preclude home monitoring

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,233 participants in 14 patient groups

PREP/PEP at Outpatient Clinics Dynamic Prevention Intervention
Experimental group
Treatment:
Other: PrEP/PEP at Outpatient Clinics
PREP/PEP at Outpatient Clinics Control
Active Comparator group
Treatment:
Other: Standard of Care
PREP/PEP at Antenatal Clinics Dynamic Prevention Intervention
Experimental group
Treatment:
Other: PrEP/PEP at Antenatal Clinics
PREP/PEP at Antenatal Clinics Control
Active Comparator group
Treatment:
Other: Standard of Care
PREP/PEP at Community Households Dynamic Prevention Intervention
Experimental group
Treatment:
Other: PrEP/PEP at Community Households
PREP/PEP at Community Households Control
Active Comparator group
Treatment:
Other: Standard of Care
Mobility Dynamic Treatment Intervention
Experimental group
Treatment:
Other: Mobility Dynamic Treatment Intervention
Mobility Control
Active Comparator group
Treatment:
Other: Standard of Care
Healthy Living for Heavy Alcohol Users Intervention
Experimental group
Treatment:
Other: Health Living Intervention for Heavy Alcohol Users
Heavy Alcohol Users Control
Active Comparator group
Treatment:
Other: Standard of Care
Hypertension Linkage Intervention
Experimental group
Treatment:
Other: Hypertension Linkage
Hypertension Linkage Control
Active Comparator group
Treatment:
Other: Standard of Care
Hypertension Community Intervention
Experimental group
Treatment:
Other: Hypertension Community
Hypertension Community Control
Active Comparator group
Treatment:
Other: Standard of Care

Trial documents
3

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems